Jan Ter Meulen

Jan Ter Meulen

Company: Obsidian Therapeutics

Job title: Chief Scientific Officer


Gene Engineering to Improve Cell Function in the Tumor Microenvironment 12:30 pm

Review the challenges of low transduction efficiencies of TIL cells selected from hostile tumor environments, what can be done to improve this? Gene modification strategies to improve T-cell resistance, ability to migrate and infiltrate tumors, and targeting Share engineering strategies to overcome the suppressive tumor microenvironmentRead more

day: Conference Day 2

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.